维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="CIL T"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Lanfivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen(HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy显示文摘	Cil T Altintas A Pasa S	2008	Leuk Lymphoma2008，49，5：	1
2	The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura显示文摘	Pasa S Altintas A Cil T	2009	J Thromb Thrombolysis2009，27，3：	1
3	Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HB- SAG) seropositive cancer patients undergoing cytotoxic chemo- therapy显示文摘	Cil T Altintas A Pasa S	2008	Leuk Lymphoma2008，49，5：	1
4	Factors affecting axillary lymph node retrieval and assessment in breast cancer patients 显示文摘	Cil T Hauspy J Kahn H	2008	Ann Surg Oneol2008，15，12：	1
5	Lanfivudine for the prevention of hepatitis-B surface antigen (HBSAG)seropositive cancer patients undergoing cytotoxic chemotherapy显示文摘	Cil T Altintas A Pasa S	2008	Leuk lymphoma2008，49，5：	1
6	Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) sempositive cancer patients undergoing cytotoxic chemotherapy 显示文摘	Cil T Ahintas A Pasa S	2008	Leuk Lymphoma2008，49，5：	1
7	Primary spindle cell sarcoma of the breast 显示文摘	Cil T Altintas A Pasa S	2008	Breast Care ( Basel)2008，3，3：	1
8	The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura显示文摘	PASA S ALTINTAS A CIL T	2009	J Thromb Thrombolysis2009，27，：	1
9	The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura 显示文摘	Pasa S Altintas A Cil T	2009	J Thromb Thrombolysis2009，27，3：	1
10	Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy显示文摘	Cil T Ahintas A Pasa S	2008	Leuk Lymphoma2008，49，5：	1
11	Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen(HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy 显示文摘	Cil T Altintas A Pasa S	2008	Leuk Lymphoma2008，49，5：	1
12	Lanilvudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen ( HB- SAG) serepositive cancer patients undergoing cytotoxic chemotherapy显示文摘	Cil T Altintas A Pasa S	2008	Leuk lymphoma2008，49，5：	1
13	The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura 显示文摘	Pasa S Ahlntas A Cil T	2009	J Thromb Thrombolysis2009，27，3：	1
14	Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients:a prospective series显示文摘	CIL T KAPLAN A M ALTINTAS A	2009	Clin Drug Investig2009，29，2：	1
15	Virological and clinical characteri- zations of respiratory infections in hospitalized children 显示文摘	Bicer S Giray T cil D	2013	Ital J Pediatr2013，39，：	1
16	Lanfivudine for the prevention of hepatitis B virus reactivation in hepatitis- B surface antigen ( HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy 显示文摘	Cil T Altintas A Pass S	2008	Leuk Lymphoma2008，49，5：	1
17	Lanfivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen ( HB- SAG) seropositive cancer patients undergoing cytotoxic chemother- apy显示文摘	Cil T Altintas A Pass S	2008	Leuk lymphonla2008，49，5：	1
18	Hyperbaric oxygen therapy for non-healing wounds显示文摘	Kulikovsky M Cil T Mettanes I	2009	Isr Med Assoc J2009，11，8：	1
19	Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection显示文摘	Abdallah FW Morgan PJ Cil T	2014	Anesthesiology2014，120，3：	1
20	DNA and RNA oxidative damage in hepatocellular carcinoma patients and mortality during the first year of liver transplantation显示文摘BACKGROUND Oxidative damage of DNA and RNA has been associated with mortality of patients with different diseases.However,there is no published data on the potential use of DNA and RNA oxidative damage to predict the prognosis of patients with hepatocellular carcinoma(HCC)undergoing liver transplantation(LT).AIM To determine whether patients with increased DNA and RNA oxidative damage prior to LT for HCC have a poor LT prognosis.METHODS Patients with HCC who underwent LT were included in this observational and retrospective study.Serum levels of all three oxidized guanine species(OGS)were measured prior to LT since guanine is the nucleobase that forms DNA and RNA most prone to oxidation.LT mortality at 1 year was the end-point study.RESULTS Surviving patients(n=101)showed lower serum OGS levels(P=0.01)and lower age of the liver donor(P=0.03)than non-surviving patients(n=13).An association between serum OGS levels prior to LT and 1-year LT(odds ratio=2.079;95%confidence interval=1.356-3.189;P=0.001)was found in the logistic regression analysis.CONCLUSION The main new finding was that high serum OGS concentration prior to LT was associated with the mortality 1 year after LT in HCC patients.	Leonardo Lorente Sergio T Rodriguez Pablo Sanz Agustín F González-Rivero Antonia Pérez-Cejas Javier Padilla Dácil Díaz Antonio González María M Martín Alejandro Jiménez Purificación Cerro Julián Portero Manuel A Barrera	2022	World Journal of Hepatology2022，14，6：	0

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示